3 Takeaways As FDA Dishes On Interchangeable Biosimilars, Law360
Tuesday, January 17, 2017
IP partner Christopher Betti, Ph.D. was quoted in a Law360 article on recent FDA guidance. Chris, along with other attorneys, talk about the FDA’s guidance on biosimilar interchangeability and its implications.